Global Tetrahydrocurcumin (CAS 36062-04-1) Competitive Landscape Professional Research Report 2025
Description
Global Tetrahydrocurcumin (CAS 36062-04-1) Competitive Landscape Professional Research Report 2025
Research Summary
Tetrahydrocurcumin, with the Chemical Abstracts Service (CAS) number 36062-04-1, is a derivative of curcumin, which is a natural compound found in turmeric. Tetrahydrocurcumin is produced by the reduction of curcumin and is known for its antioxidant and anti-inflammatory properties. It is considered to be more stable and bioavailable than curcumin, making it a promising compound for various pharmaceutical and cosmetic applications. Research suggests that tetrahydrocurcumin may have potential health benefits, including anti-cancer, anti-diabetic, neuroprotective, and skin-protective effects. It is commonly used as an active ingredient in dietary supplements, skincare products, and pharmaceutical formulations aimed at promoting overall health and wellness.
According to DIResearch's in-depth investigation and research, the global Tetrahydrocurcumin (CAS 36062-04-1) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Tetrahydrocurcumin (CAS 36062-04-1) include Huateng Pharma, Hangzhou Great Forest, Hangzhou Lingeba Technology, Hangzhou Linran Biotechnology, Plamed Green Science, Sinoway Industrial etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Tetrahydrocurcumin (CAS 36062-04-1). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Tetrahydrocurcumin (CAS 36062-04-1) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Tetrahydrocurcumin (CAS 36062-04-1) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Tetrahydrocurcumin (CAS 36062-04-1) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Tetrahydrocurcumin (CAS 36062-04-1) Include:
Huateng Pharma
Hangzhou Great Forest
Hangzhou Lingeba Technology
Hangzhou Linran Biotechnology
Plamed Green Science
Sinoway Industrial
Tetrahydrocurcumin (CAS 36062-04-1) Product Segment Include:
Purity: ≥98%
Purity: <98%
Tetrahydrocurcumin (CAS 36062-04-1) Product Application Include:
Cosmetics
Pharmaceutical
Food
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Tetrahydrocurcumin (CAS 36062-04-1) Capacity and Production Analysis
Chapter 3: Global Tetrahydrocurcumin (CAS 36062-04-1) Industry PESTEL Analysis
Chapter 4: Global Tetrahydrocurcumin (CAS 36062-04-1) Industry Porter's Five Forces Analysis
Chapter 5: Global Tetrahydrocurcumin (CAS 36062-04-1) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 6: Global Tetrahydrocurcumin (CAS 36062-04-1) Market Size and Forecast by Type and Application Analysis
Chapter 7: North America Tetrahydrocurcumin (CAS 36062-04-1) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: Europe Tetrahydrocurcumin (CAS 36062-04-1) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: China Tetrahydrocurcumin (CAS 36062-04-1) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: APAC (Excl. China) Tetrahydrocurcumin (CAS 36062-04-1) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Latin America Tetrahydrocurcumin (CAS 36062-04-1) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Middle East and Africa Tetrahydrocurcumin (CAS 36062-04-1) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 13: Global Tetrahydrocurcumin (CAS 36062-04-1) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 16: Research Findings and Conclusion
Chapter 17: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Tetrahydrocurcumin (CAS 36062-04-1) Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Tetrahydrocurcumin (CAS 36062-04-1) Product by Type
- 1.2.1 Purity: ≥98%
- 1.2.2 Purity: <98%
- 1.3 Tetrahydrocurcumin (CAS 36062-04-1) Product by Application
- 1.3.1 Cosmetics
- 1.3.2 Pharmaceutical
- 1.3.3 Food
- 1.4 Global Tetrahydrocurcumin (CAS 36062-04-1) Market Revenue and Sales Analysis
- 1.4.1 Global Tetrahydrocurcumin (CAS 36062-04-1) Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Tetrahydrocurcumin (CAS 36062-04-1) Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Tetrahydrocurcumin (CAS 36062-04-1) Market Sales Price Trend Analysis (2020-2032)
- 1.5 Tetrahydrocurcumin (CAS 36062-04-1) Industry Trends and Innovation
- 1.5.1 Tetrahydrocurcumin (CAS 36062-04-1) Industry Trends and Innovation
- 1.5.2 Tetrahydrocurcumin (CAS 36062-04-1) Market Drivers and Challenges
- 2 Global Tetrahydrocurcumin (CAS 36062-04-1) Capacity and Production Analysis
- 2.1 Global Tetrahydrocurcumin (CAS 36062-04-1) Capacity, Production and Utilization (2020-2032)
- 2.2 Global Tetrahydrocurcumin (CAS 36062-04-1) Production Growth Trend by Region: 2024 VS 2025 VS 2030
- 2.3 Global Tetrahydrocurcumin (CAS 36062-04-1) Production by Region
- 2.3.1 Global Tetrahydrocurcumin (CAS 36062-04-1) Production by Region (2020-2025)
- 2.3.2 Global Tetrahydrocurcumin (CAS 36062-04-1) Production Forecast by Region (2026-2032)
- 2.3.3 Global Tetrahydrocurcumin (CAS 36062-04-1) Production Market Share by Region (2020-2032)
- 3 Tetrahydrocurcumin (CAS 36062-04-1) Market PESTEL Analysis
- 3.1 Political Factors Analysis
- 3.2 Economic Factors Analysis
- 3.3 Social Factors Analysis
- 3.4 Technological Factors Analysis
- 3.5 Environmental Factors Analysis
- 3.6 Legal Factors Analysis
- 4 Tetrahydrocurcumin (CAS 36062-04-1) Market Porter's Five Forces Analysis
- 4.1 Competitive Rivalry
- 4.2 Threat of New Entrants
- 4.3 Bargaining Power of Suppliers
- 4.4 Bargaining Power of Buyers
- 4.5 Threat of Substitutes
- 5 Global Tetrahydrocurcumin (CAS 36062-04-1) Market Analysis by Regions
- 5.1 Tetrahydrocurcumin (CAS 36062-04-1) Overall Market: 2024 VS 2025 VS 2032
- 5.2 Global Tetrahydrocurcumin (CAS 36062-04-1) Revenue and Forecast Analysis (2020-2032)
- 5.2.1 Global Tetrahydrocurcumin (CAS 36062-04-1) Revenue and Market Share by Region (2020-2025)
- 5.2.2 Global Tetrahydrocurcumin (CAS 36062-04-1) Revenue and Market Forecast by Region (2026-2032)
- 5.3 Global Tetrahydrocurcumin (CAS 36062-04-1) Sales and Forecast Analysis (2020-2032)
- 5.3.1 Global Tetrahydrocurcumin (CAS 36062-04-1) Sales and Market Share by Region (2020-2025)
- 5.3.2 Global Tetrahydrocurcumin (CAS 36062-04-1) Sales and Market Forecast by Region (2026-2032)
- 5.4 Global Tetrahydrocurcumin (CAS 36062-04-1) Sales Price Trend Analysis (2020-2032)
- 6 Global Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Type and Application
- 6.1 Global Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Type
- 6.1.1 Global Tetrahydrocurcumin (CAS 36062-04-1) Revenue and Forecast Analysis by Type (2020-2032)
- 6.1.2 Global Tetrahydrocurcumin (CAS 36062-04-1) Sales and Forecast Analysis by Type (2020-2032)
- 6.2 Global Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Application
- 6.2.1 Global Tetrahydrocurcumin (CAS 36062-04-1) Revenue and Forecast Analysis by Application (2020-2032)
- 6.2.2 Global Tetrahydrocurcumin (CAS 36062-04-1) Sales and Forecast Analysis by Application (2020-2032)
- 7 North America
- 7.1 North America Tetrahydrocurcumin (CAS 36062-04-1) Market Size and Growth Rate Analysis (2020-2032)
- 7.2 North America Key Manufacturers Analysis
- 7.3 North America Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Type
- 7.3.1 North America Tetrahydrocurcumin (CAS 36062-04-1) Sales by Type (2020-2032)
- 7.3.2 North America Tetrahydrocurcumin (CAS 36062-04-1) Revenue by Type (2020-2032)
- 7.4 North America Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Application
- 7.4.1 North America Tetrahydrocurcumin (CAS 36062-04-1) Sales by Application (2020-2032)
- 7.4.2 North America Tetrahydrocurcumin (CAS 36062-04-1) Revenue by Application (2020-2032)
- 7.5 North America Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Country
- 7.5.1 US
- 7.5.2 Canada
- 8 Europe
- 8.1 Europe Tetrahydrocurcumin (CAS 36062-04-1) Market Size and Growth Rate Analysis (2020-2032)
- 8.2 Europe Key Manufacturers Analysis
- 8.3 Europe Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Type
- 8.3.1 Europe Tetrahydrocurcumin (CAS 36062-04-1) Sales by Type (2020-2032)
- 8.3.2 Europe Tetrahydrocurcumin (CAS 36062-04-1) Revenue by Type (2020-2032)
- 8.4 Europe Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Application
- 8.4.1 Europe Tetrahydrocurcumin (CAS 36062-04-1) Sales by Application (2020-2032)
- 8.4.2 Europe Tetrahydrocurcumin (CAS 36062-04-1) Revenue by Application (2020-2032)
- 8.5 Europe Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Country
- 8.5.1 Germany
- 8.5.2 France
- 8.5.3 United Kingdom
- 8.5.4 Italy
- 8.5.5 Spain
- 8.5.6 Benelux
- 9 China
- 9.1 China Tetrahydrocurcumin (CAS 36062-04-1) Market Size and Growth Rate Analysis (2020-2032)
- 9.2 China Key Manufacturers Analysis
- 9.3 China Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Type
- 9.3.1 China Tetrahydrocurcumin (CAS 36062-04-1) Sales by Type (2020-2032)
- 9.3.2 China Tetrahydrocurcumin (CAS 36062-04-1) Revenue by Type (2020-2032)
- 9.4 China Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Application
- 9.4.1 China Tetrahydrocurcumin (CAS 36062-04-1) Sales by Application (2020-2032)
- 9.4.2 China Tetrahydrocurcumin (CAS 36062-04-1) Revenue by Application (2020-2032)
- 10 APAC (excl. China)
- 10.1 APAC (excl. China) Tetrahydrocurcumin (CAS 36062-04-1) Market Size and Growth Rate Analysis (2020-2032)
- 10.2 APAC (excl. China) Key Manufacturers Analysis
- 10.3 APAC (excl. China) Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Type
- 10.3.1 APAC (excl. China) Tetrahydrocurcumin (CAS 36062-04-1) Sales by Type (2020-2032)
- 10.3.2 APAC (excl. China) Tetrahydrocurcumin (CAS 36062-04-1) Revenue by Type (2020-2032)
- 10.4 APAC (excl. China) Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Application
- 10.4.1 APAC (excl. China) Tetrahydrocurcumin (CAS 36062-04-1) Sales by Application (2020-2032)
- 10.4.2 APAC (excl. China) Tetrahydrocurcumin (CAS 36062-04-1) Revenue by Application (2020-2032)
- 10.5 APAC (excl. China) Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Country
- 10.5.1 Japan
- 10.5.2 South Korea
- 10.5.3 India
- 10.5.4 Australia
- 10.5.5 Southeast Asia
- 11 Latin America
- 11.1 Latin America Tetrahydrocurcumin (CAS 36062-04-1) Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Latin America Key Manufacturers Analysis
- 1`.3 Latin America Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Type
- 11.3.1 Latin America Tetrahydrocurcumin (CAS 36062-04-1) Sales by Type (2020-2032)
- 11.3.2 Latin America Tetrahydrocurcumin (CAS 36062-04-1) Revenue by Type (2020-2032)
- 11.4 Latin America Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Application
- 11.4.1 Latin America Tetrahydrocurcumin (CAS 36062-04-1) Sales by Application (2020-2032)
- 11.4.2 Latin America Tetrahydrocurcumin (CAS 36062-04-1) Revenue by Application (2020-2032)
- 11.5 Latin America Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Country
- 11.6 Latin America Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Country
- 11.6.1 Mexico
- 11.6.2 Brazil
- 12 Middle East & Africa
- 12.1 Middle East & Africa Tetrahydrocurcumin (CAS 36062-04-1) Market Size and Growth Rate Analysis (2020-2032)
- 12.2 Middle East & Africa Key Manufacturers Analysis
- 12.3 Middle East & Africa Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Type
- 12.3.1 Middle East & Africa Tetrahydrocurcumin (CAS 36062-04-1) Sales by Type (2020-2032)
- 12.3.2 Middle East & Africa Tetrahydrocurcumin (CAS 36062-04-1) Revenue by Type (2020-2032)
- 12.4 Middle East & Africa Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Application
- 12.4.1 Middle East & Africa Tetrahydrocurcumin (CAS 36062-04-1) Sales by Application (2020-2032)
- 12.4.2 Middle East & Africa Tetrahydrocurcumin (CAS 36062-04-1) Revenue by Application (2020-2032)
- 12.5 Middle East Tetrahydrocurcumin (CAS 36062-04-1) Market Size by Country
- 12.5.1 Saudi Arabia
- 12.5.2 South Africa
- 13 Competition by Manufacturers
- 13.1 Global Tetrahydrocurcumin (CAS 36062-04-1) Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 13.1.1 Global Tetrahydrocurcumin (CAS 36062-04-1) Market Sales by Key Manufacturers (2021-2025)
- 13.1.2 Global Tetrahydrocurcumin (CAS 36062-04-1) Market Revenue by Key Manufacturers (2021-2025)
- 13.1.3 Global Tetrahydrocurcumin (CAS 36062-04-1) Average Sales Price by Manufacturers (2021-2025)
- 13.2 Tetrahydrocurcumin (CAS 36062-04-1) Competitive Landscape Analysis and Market Dynamic
- 13.2.1 Tetrahydrocurcumin (CAS 36062-04-1) Competitive Landscape Analysis
- 13.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 13.2.3 Market Dynamic
- 14 Key Companies Analysis
- 14.1 Huateng Pharma
- 14.1.1 Huateng Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.1.2 Huateng Pharma Tetrahydrocurcumin (CAS 36062-04-1) Product Portfolio
- 14.1.3 Huateng Pharma Tetrahydrocurcumin (CAS 36062-04-1) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.2 Hangzhou Great Forest
- 14.2.1 Hangzhou Great Forest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.2.2 Hangzhou Great Forest Tetrahydrocurcumin (CAS 36062-04-1) Product Portfolio
- 14.2.3 Hangzhou Great Forest Tetrahydrocurcumin (CAS 36062-04-1) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.3 Hangzhou Lingeba Technology
- 14.3.1 Hangzhou Lingeba Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.3.2 Hangzhou Lingeba Technology Tetrahydrocurcumin (CAS 36062-04-1) Product Portfolio
- 14.3.3 Hangzhou Lingeba Technology Tetrahydrocurcumin (CAS 36062-04-1) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.4 Hangzhou Linran Biotechnology
- 14.4.1 Hangzhou Linran Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.4.2 Hangzhou Linran Biotechnology Tetrahydrocurcumin (CAS 36062-04-1) Product Portfolio
- 14.4.3 Hangzhou Linran Biotechnology Tetrahydrocurcumin (CAS 36062-04-1) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.5 Plamed Green Science
- 14.5.1 Plamed Green Science Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.5.2 Plamed Green Science Tetrahydrocurcumin (CAS 36062-04-1) Product Portfolio
- 14.5.3 Plamed Green Science Tetrahydrocurcumin (CAS 36062-04-1) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.6 Sinoway Industrial
- 14.6.1 Sinoway Industrial Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.6.2 Sinoway Industrial Tetrahydrocurcumin (CAS 36062-04-1) Product Portfolio
- 14.6.3 Sinoway Industrial Tetrahydrocurcumin (CAS 36062-04-1) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 15 Industry Chain Analysis
- 15.1 Tetrahydrocurcumin (CAS 36062-04-1) Industry Chain Analysis
- 15.2 Tetrahydrocurcumin (CAS 36062-04-1) Industry Raw Material and Suppliers Analysis
- 15.2.1 Tetrahydrocurcumin (CAS 36062-04-1) Key Raw Material Supply Analysis
- 15.2.2 Raw Material Suppliers and Contact Information
- 15.3 Tetrahydrocurcumin (CAS 36062-04-1) Typical Downstream Customers
- 15.4 Tetrahydrocurcumin (CAS 36062-04-1) Sales Channel Analysis
- 16 Research Findings and Conclusion
- 17 Methodology and Data Source
- 17.1 Methodology/Research Approach
- 17.2 Research Scope
- 17.3 Benchmarks and Assumptions
- 17.4 Date Source
- 17.4.1 Primary Sources
- 17.4.2 Secondary Sources
- 17.5 Data Cross Validation
- 17.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

